Literature DB >> 7556319

Histiocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state.

S Ohga1, A Ooshima, J Fukushige, K Ueda.   

Abstract

UNLABELLED: A 32-month-old Japanese boy exhibited haemophagocytic syndrome (HPS) during the recurrent course of Kawasaki disease. Despite repeated gamma-globulin therapy, he developed cytopenia with marked hepatomegaly and evidence of histiocytic haemophagocytosis in the bone marrow. Serum levels of interferon-gamma and tumour necrosis factor, but not of interleukin-1 beta, increased in parallel with his symptoms. No confirmation was obtained of the association of toxic reactions to the used drugs. No coronary lesions remained as sequelae.
CONCLUSION: Cytopenia in Kawasaki disease could herald HPS, and the hypercytokinaemia involved in the two febrile syndromes might be of distinct nature.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556319     DOI: 10.1007/bf02074830

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

Review 1.  Interleukin-1: biology, pathophysiology, and clinical prospects.

Authors:  L C Platanias; N J Vogelzang
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

2.  Thrombocytopenia: a complication of Kawasaki disease.

Authors:  T Hara; Y Mizuno; H Akeda; J Fukushige; K Ueda; T Aoki; H Sunagawa; S Honda; T Hijii; Y Yamaguchi
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

3.  Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes.

Authors:  D M Komp; J McNamara; P Buckley
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

4.  Kawasaki's syndrome accompanied by bone marrow suppression.

Authors:  I Cohen; M Whistler
Journal:  J La State Med Soc       Date:  1988-07

5.  Virus-associated haemophagocytic syndrome: further evidence for a T-cell mediated disorder.

Authors:  H G Watson; N J Goulden; L M Manson; G McDermid; J A Gray; A C Parker
Journal:  Br J Haematol       Date:  1994-01       Impact factor: 6.998

6.  Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity.

Authors:  S Ohga; A Matsuzaki; M Nishizaki; T Nagashima; T Kai; M Suda; K Ueda
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-08

7.  Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor.

Authors:  E Ishii; S Ohga; T Aoki; S Yamada; M Sako; H Tasaka; A Kuwano; M Sasaki; Y Tsunematsu; K Ueda
Journal:  Acta Haematol       Date:  1991       Impact factor: 2.195

Review 8.  Clinical and immunologic aspects of Kawasaki disease.

Authors:  D Y Leung
Journal:  Immunodefic Rev       Date:  1989

9.  Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.

Authors:  C Y Lin; C C Lin; B Hwang; B Chiang
Journal:  J Pediatr       Date:  1992-12       Impact factor: 4.406

10.  Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.

Authors:  D Y Leung; H C Meissner; D R Fulton; D L Murray; B L Kotzin; P M Schlievert
Journal:  Lancet       Date:  1993-12-04       Impact factor: 79.321

View more
  7 in total

1.  Langerhans histiocytosis, haemophagocytic syndrome and Epstein-Barr virus infection.

Authors:  Lucien Corbeel
Journal:  Eur J Pediatr       Date:  2004-07-09       Impact factor: 3.183

2.  Forme Fruste of HLH (haemophagocytic lymphohistiocytosis): diagnostic and therapeutic challenges.

Authors:  Susumu Inoue; Chetna Mangat; Yaseen Rafe'e; Mahesh Sharman
Journal:  BMJ Case Rep       Date:  2015-01-29

3.  Very high serum ferritin levels in three newborns with Kawasaki-like illness.

Authors:  Arwa Nasir; Hosam Al Tatari; Mohamed A Hamdan
Journal:  Paediatr Child Health       Date:  2012-04       Impact factor: 2.253

4.  Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease.

Authors:  Hae-Ryong Kang; Yong-Hoon Kwon; Eun-Sun Yoo; Kyung-Ha Ryu; Ji Yoon Kim; Heung-Sik Kim; Hwang Min Kim; Young-Ho Lee
Journal:  Blood Res       Date:  2013-12-24

5.  The use of corticosteroid therapy in refractory Kawasaki patients.

Authors:  Sulaiman M Al-Mayouf
Journal:  Clin Rheumatol       Date:  2003-12-16       Impact factor: 2.980

6.  Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide.

Authors:  Jung Eun Choi; Yujin Kwak; Jung Won Huh; Eun-Sun Yoo; Kyung-Ha Ryu; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2018-05-28

7.  Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review.

Authors:  Hongkun Jiang; Zhiliang Yang
Journal:  Front Pediatr       Date:  2020-03-10       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.